Andros Pharmaceuticals Co.,Ltd Stock

Equities

6917

TW0006917008

Pharmaceuticals

End-of-day quote Taipei Exchange 06:00:00 2024-07-02 pm EDT 5-day change 1st Jan Change
20.4 TWD +0.49% Intraday chart for Andros Pharmaceuticals Co.,Ltd +0.74% -18.07%
Dynamic Chart
1 day+0.49%
1 week+0.74%
Current month+2.00%
1 month-2.63%
3 months-8.11%
6 months-17.41%
Current year-18.07%
More quotes
1 week
19.80
Extreme 19.8
20.45
1 month
19.80
Extreme 19.8
21.00
Current year
19.80
Extreme 19.8
26.60
1 year
19.80
Extreme 19.8
38.70
3 years
19.80
Extreme 19.8
46.30
5 years
19.80
Extreme 19.8
46.30
10 years
19.80
Extreme 19.8
46.30
More quotes
Managers TitleAgeSince
Chief Executive Officer - 08-06-30
Chief Operating Officer - -
More insiders
Date Price Change Volume
24-07-03 20.4 +0.49% 87,092
24-07-02 20.3 +1.00% 50,133
24-07-01 20.1 +0.50% 66,753
24-06-28 20 -0.99% 129,461
24-06-27 20.2 -0.25% 57,315

End-of-day quote Taipei Exchange, July 02, 2024

More quotes
Andros Pharmaceuticals Co Ltd is a Taiwan-based company mainly engaged in the research, design, development, manufacture and sales of novel drug delivery systems and liposome formulation-related products. The products are focused on topical drugs and are developed with a focus on pain-related indications. The Company is mainly engaged in the authorization of product technology transfer, as well as the manufacture and sales of niche generic drugs and high-end skin care products. Niche generic drugs and high-end skin care products include LALP Cream, which is used for anesthesia before minor skin surgery and laser treatment; iMinos Solution, which is used for the treatment of androgenetic alopecia; and deoxyribonucleic acid (DNA) repair enzyme liposome (LipoT4N5), which has anti-wrinkle, anti-sun and anti-aging effects. The products are mainly sold in Hong Kong and Taiwan.
More about the company